Also, while genetically engineered models can replicate individual mutations like TP53 or SF3B1, they can fail to capture the clonal complexity of human MDS, where the sequential accumulation of mutations such as TET2, ASXL1, and splicing factors drives disease progression [14]. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.